Global Huntington's Disease Therapeutics Market Report 2021: Market to Reach $3.1 Billion by 2027 - U.S. Market is Estimated at $107.7 Million, While China is Forecast to Grow at 41.6% CAGR - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Huntington's Disease Therapeutics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Global Huntington's Disease Therapeutics Market to Reach $3.1 Billion by 2027
Amid the COVID-19 crisis, the global market for Huntington's Disease Therapeutics estimated at US$402.2 Million in the year 2020, is projected to reach a revised size of US$3.1 Billion by 2027, growing at a CAGR of 33.7% over the period 2020-2027.
The U.S. Market is Estimated at $107.7 Million, While China is Forecast to Grow at 41.6% CAGR
The Huntington's Disease Therapeutics market in the U.S. is estimated at US$107.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$821 Million by the year 2027 trailing a CAGR of 41.6% over the analysis period 2020 to 2027.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 26.9% and 30.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 28.9% CAGR.
Key Topics Covered:
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS (Total 25 Featured):
- Alnylam Pharmaceuticals, Inc.
- Evotec AG
- GlaxoSmithKline PLC
- Horizon Therapeutics plc
- Ionis Pharmaceuticals, Inc.
- Raptor Pharmaceutical Corporation
- Sangamo Biosciences, Inc.
- Suven Life Sciences Ltd.
- Teva Pharmaceutical Industries Ltd.
- Vertex Pharmaceuticals Inc.
- Wave Life Sciences Ltd.
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
- World Current & Future Analysis for Huntington's Disease Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
- World Historic Review for Huntington's Disease Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- World 15-Year Perspective for Huntington's Disease Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
- United States
- United Kingdom
- Rest of Europe
- South Korea
- Rest Of Asia-Pacific
- Latin America
- Rest of Latin America
- Middle East
- Saudi Arabia
- United Arab Emirates
- Rest of Middle East
For more information about this report visit https://www.researchandmarkets.com/r/wiwg4x
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900